Cargando…
The Urinary Microbiome and Bladder Cancer
Bladder cancer is the 10th most common cancer worldwide. Approximately 75% of patients with bladder cancer will present with non-muscle invasive disease. Patients are usually treated with transurethral resection of bladder tumor (TURBT), in addition to adjuvant intravesical therapy (chemotherapy or...
Autores principales: | Heidar, Nassib Abou, Bhat, Tariq A., Shabir, Usma, Hussein, Ahmed A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10053959/ https://www.ncbi.nlm.nih.gov/pubmed/36983967 http://dx.doi.org/10.3390/life13030812 |
Ejemplares similares
-
Management of urinary tract infection in women: A practical approach for everyday practice
por: Abou Heidar, Nassib F., et al.
Publicado: (2019) -
The Urinary Microbiome: Role in Bladder Cancer and Treatment
por: Friedrich, Veronika, et al.
Publicado: (2022) -
Acquired Bilateral Seminal Vesicle Cysts: A Rare Manifestation of Prostate Cancer
por: Abou Heidar, Nassib, et al.
Publicado: (2019) -
Incorporating Prognostic Biomarkers into Risk Assessment Models and TNM Staging for Prostate Cancer
por: Saoud, Ragheed, et al.
Publicado: (2020) -
A Rare Case of Isolated Ureteral Diaphragmatic Herniation: Case Report and Review of Literature
por: Abou Heidar, Nassib, et al.
Publicado: (2019)